하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.
하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.
It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.
SEOUL, Korea – The 2025 Key Aesthetic Brand Joint Symposium with HUMANS successfully concluded on July 5 at the Voco Gangnam Hotel (IHG) in Seoul. Held under the theme “All About Lifting Boosters,” the symposium brought together leading dermatologists to share clinical insights and the latest trends in skin elasticity and natural lifting treatments.
Hosted by the Human Dermatology Network and sponsored by four major aesthetic medical device brands including HIRONIC, the event combined academic depth with practical relevance. Participating dermatologists exchanged treatment know-how and explored the future of personalized patient care through discussions on technological advancements.
HIRONIC took the spotlight with its non-invasive skin booster device, SYNERJET. Utilizing high-speed microjet technology, SYNERJET delivers skin booster formulations evenly across the dermis without needles. With a maximum of 20 shots per second and a delivery velocity of 580 m/s, the system minimizes pain and side effects while enhancing treatment efficacy.
The device's engineering precision was also notable. SYNERJET features microcurrent stimulation, penetration enhancement, a handpiece cooling system, three interchangeable tips with adjustable injection depth, and 27 preset protocols—ensuring both safety and efficiency. The system enables tailored treatment based on the patient’s skin condition while maximizing convenience for clinicians.
As the aesthetic industry evolves from traditional lifting to regenerative and hydrating skin booster therapies, SYNERJET is gaining recognition as a device aligned with this new direction. Its growing clinical adoption and rising satisfaction among medical professionals underscore its value in modern dermatological practice.
“The symposium offered valuable insight into rapidly evolving trends and technologies in aesthetic medicine,” the organizers stated. “Thanks to the cooperation of sponsors like HIRONIC, the event was a great success.”
They added, “HIRONIC’s continued innovation and R&D efforts are helping elevate treatment quality and patient satisfaction in dermatology. We look forward to building a safer and more effective anti-aging culture in partnership with trusted industry leaders.”
Beyond academic exchange, the
event received strong engagement for its focus on real-world applications and
practical solutions for clinical settings. The organizers plan to hold future
symposiums to further enhance the quality and expertise of dermatology
services.
